Nama's AI scorecard currently rates Core Scientific Sell (2.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CORZ's P/E ratio?

Core Scientific trades at a trailing price-to-earnings ratio of 392.0.

When does CORZ report earnings?

Core Scientific's next scheduled report is on Mar 1, 2027. Analysts expect EPS of $0.16.

What is the CORZ price target?

The median analyst price target from 21 analysts is $31.00, with a range of $16.00 – $47.00.

Is CORZ Shariah compliant?

Nama's AAOIFI-style screen reads Core Scientific as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Nama Insights

Core Scientific (CORZ)

Technology · Software Infrastructure · NASDAQ

Core Scientific (CORZ) is a Technology company in the Software Infrastructure industry. It has a market capitalization of $3.78B, a trailing price-to-earnings ratio of 392.0 and a free-cash-flow yield of -12.0%. Over the most recent reported fiscal year, revenue declined 37.5%. Nama's AI scorecard rates it Sell, 2.5 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Sell · 2.5/10

Clearly negative, short of the bottom band. As of Nov 7, 2026.

Momentum

Lagging · -22.6% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-61.4%

How far the last close sits under the highest price of the past five years.

Market cap	$3.78B
Trailing P/E	392.0
Price / book	—
Price / sales	8.6
FCF yield	-12.0%
Dividend yield	—
Gross margin	28.4%
Operating margin	-46.8%
Net margin	-325.3%
Revenue growth (YoY)	-37.5%
Revenue growth (3-yr annual)	-20.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Beta	5.5
Exchange	NASDAQ
Sector	Technology
Industry	Software Infrastructure

CORZ earnings

Next report: Mar 1, 2027 (Q4 2026, EPS estimate $0.16). Beat the EPS estimate in 2 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 5, 2026	$0.36	$0.00	—	—
Q2 2026	Jul 28, 2026	-$0.04	-$0.06	+33.3%	$164.20M
Q1 2026	May 6, 2026	-$0.11	-$0.05	-120.0%	$115.24M
Q4 2025	Mar 2, 2026	-$0.18	-$0.12	-50.0%	$79.76M

CORZ analyst price target

Median target $31.00 from 21 analysts, ranging $16.00 – $47.00.

Software Infrastructure peers

Ticker	Company	Market cap	P/E
MSFT	Microsoft	$3.94T	29.4
PLTR	Palantir Technologies	$386.44B	112.2
ORCL	Oracle	$361.97B	14.4
PANW	Palo Alto Networks	$256.86B	81.9
CRWD	CrowdStrike	$222.09B	195.4
NET	Cloudflare	$95.70B	224.0
FTNT	Fortinet	$87.31B	34.5
SNPS	Synopsys	$86.32B	32.3

Explore live CORZ data on Nama Insights →

CORZ FAQ

Is CORZ a buy?: Nama's AI scorecard currently rates Core Scientific Sell (2.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CORZ's P/E ratio?: Core Scientific trades at a trailing price-to-earnings ratio of 392.0.
When does CORZ report earnings?: Core Scientific's next scheduled report is on Mar 1, 2027. Analysts expect EPS of $0.16.
What is the CORZ price target?: The median analyst price target from 21 analysts is $31.00, with a range of $16.00 – $47.00.
Is CORZ Shariah compliant?: Nama's AAOIFI-style screen reads Core Scientific as Not Shariah Compliant. At least one of the three ratios or the industry test failed.